Search results
Iovance's (IOVA) Meets Q3 Earnings, Lags Sales Estimates
Zacks via Yahoo Finance· 6 months agoIovance Biotherapeutics, Inc. IOVA incurred a loss of 46 cents per share in third-quarter 2023, in...
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
Zacks via Yahoo Finance· 1 month agoIovance (IOVA) surges on the recent FDA approval for its lead pipeline drug as the first...
Iovance (IOVA) Posts Narrower-Than-Expected Loss in Q1
Zacks via Yahoo Finance· 1 year agoIovance (IOVA) reports Q1 earnings that beat our estimates. The company's acquisition of IL-2...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 week agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%
Zacks via Yahoo Finance· 1 year agoIovance (IOVA) to acquire worldwide rights to an IL-2 product already approved by FDA for two cancer...
Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates
Zacks via Yahoo Finance· 2 months agoIovance (IOVA) reports dismal earnings in the fourth quarter. Management is in the process of...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 4 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...